Suppr超能文献

人纯化CD8 + T细胞:用于产生最大产量功能性细胞毒性细胞的体外扩增模型。

Human purified CD8+ T cells: Ex vivo expansion model to generate a maximum yield of functional cytotoxic cells.

作者信息

Al-Shanti Nasser, Aldahoudi Ziyad

机构信息

Institute for Clinical Research into Human Movement, Manchester Metropolitan University, Hassall Road, Alsager, Stoke-on-Trent, England.

出版信息

Immunol Invest. 2007;36(1):85-104. doi: 10.1080/08820130600991950.

Abstract

CD8+ T cells are a critical component of the cellular immune response. They play an important role in the control of viral infection and eliminating cells with malignant potential. However, attempts to generate and expand human CD8+ T cells in vitro for an adoptive immunotherapy have been conducted with limitation of the very low frequency of CD8+ T cells in blood. Therefore, several expansion protocols have been developed to obtain large and efficient numbers of human CD8+ T cells for use in adoptive immunotherapies. In this study various common culture conditions using different cytokines IL-2, IL-4, IL-7, IL-10, IL-12 and IL-15 and autologous feeders and sera were investigated to expand human purified CD8+ T cells. The importance and the influence of these factors on the growth and phenotype of CD8+ T cell were assessed by serially sampling cultures using flow cytometry. We demonstrated that combination of IL-2 (50 U/ml) and autologous feeders induced maximal CD8+ T cell proliferation (40-50 folds) compared to other cytokines. Immunophenotypic analysis of cultured cells showed that expanded CD8+ T cells were activated and differentiated. Furthermore our expansion model also demonstrated that expanded CD8+ T cells are functionally cytotoxic active by killing Allogeneic LCLs cells. In conclusion, we have developed a reliable, simple method that uses minimal cell numbers to generate a high yield of functional cytotoxic CD8+ T cells, which can be used for the development of cellular immunotherapies.

摘要

CD8 + T细胞是细胞免疫反应的关键组成部分。它们在控制病毒感染和清除具有恶性潜能的细胞方面发挥着重要作用。然而,由于血液中CD8 + T细胞频率极低,在体外生成和扩增用于过继性免疫疗法的人CD8 + T细胞的尝试受到了限制。因此,已经开发了几种扩增方案,以获得大量高效的人CD8 + T细胞用于过继性免疫疗法。在本研究中,研究了使用不同细胞因子IL-2、IL-4、IL-7、IL-10、IL-12和IL-15以及自体饲养细胞和血清的各种常见培养条件,以扩增人纯化的CD8 + T细胞。通过使用流式细胞术对培养物进行连续取样,评估了这些因素对CD8 + T细胞生长和表型的重要性和影响。我们证明,与其他细胞因子相比,IL-2(50 U/ml)和自体饲养细胞的组合诱导了最大程度的CD8 + T细胞增殖(40 - 50倍)。对培养细胞的免疫表型分析表明,扩增的CD8 + T细胞被激活并分化。此外,我们的扩增模型还表明,扩增的CD8 + T细胞通过杀伤异基因LCLs细胞具有功能性细胞毒性活性。总之,我们开发了一种可靠、简单的方法,该方法使用最少的细胞数量来产生高产率的功能性细胞毒性CD8 + T细胞,可用于细胞免疫疗法的开发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验